e-ESO Podcasts
Detajet e Kanalit
e-ESO Podcasts
e-ESO is the online platform of the European School of Oncology providing sponsor-free, open access quality education wherever you are in the world. www.e-Eso.net
Episode të Fundit
134 episode
Angiosarcoma Essentials
Experts:
Salvatore Provenzano, Medical Oncology Unit 2 - Mesenchymal and rare cancer, Fondazione
IRCCS Istituto Nazionale dei Tumori, Mila...
The Lines of Therapy After Progression on CDK4/6 Inhibitors Plus Endocrine Therapy to Overcome the Resistance in HR+/Her2 - Metastatic Breast Cancer Patients
Eman Aboelkheir, Alexandria University, Alexandria, Egypt
Women’s Health Frontiers: Breakthroughs from ESMO 2024
Expert: Elvina Almuradova, Medicana International Hospital, Izmir, Turkey
ESMO Congress Prostate Cancer Highlights
Expert: Marina Puchinskaya, Minsk City Clinical Oncologic Centre, Minsk, Belarus
How to interpret prognostic models papers in hematology and oncology
Expert: Vadim Lesan, University of Saarland, Saarland, Germany
Stage III Lung Cancer Resecability
Expert: Mariana Brandao, Institut Jules Bordet, Brussels, Belgium
Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline
Expert: Sara Simões, Braga Public Hospital, Braga, PT
Clinical approach and therapeutic overview on gastroenteropancreatic neoendocrine tumours (GEP-NENS)
Expert: Francesca Spada, IEO - European Institute of Oncology, Milan, Italy
Fear of recurrence: one of the major elements in reactivating cancer
Expert: Adrian Pogacian, INCKA Psycho-Oncology Center, Târgu Mures, Romania
Immunohistochemistry in oncology
Expert: Marina Puchinskaya, Minsk City Clinical Oncologic Centre, Minsk, Belarus
Thrombosis and cachexia in cancer: Two partners in crime?
Expert: Joana Liz Pimenta, ICBAS- Abel Salazar Institute of Biomedical Sciences, Porto, Portugal
From clinical and academic culture in radiation oncology - how to cross the chasm?
Expert: Vincent Grégoire, Centre Léon Bérard, Lyon, FR
Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer
Expert: Radwa Hamed Sabra, Lecturer of Clinical Oncology, Armed Forces College of Medicine Egypt, Cairo, Egypt
Approach to severe immune-related adverse events: beyond corticosteroids and other challenges
Experts:
Paula Fidalgo, Centro Hospitalar Universitário de Santo António, Porto, PT
João Coelho, Centro Hospitalar Universitário de Santo...
Emerging Biomarkers in the Diagnosis and Treatment of Testicular Tumors
Expert: Panagiotis J. Vlachostergios, Weill Cornell Medicine, New York, NY, USA
The World Oncology Forum Amplifies Its Appeal in the Global Fight Against Cancer
Expert: Franco Cavalli, Foundation for the Institute for Oncology Research (IOR), Bellinzona, Switzerland
Immunotherapy options in the 1st line of treatment of Her2 negative advanced GEJ/Gastric Cancer, the role of CPS value
Expert: Marcelo Porfirio Sunagua Aruquipa, Grupo Oncoclinicas, San Paolo, Brazil
An inter-specialty cancer training programme curriculum for Europe
Kim Benstead, Co-Chair INTERACT-EUROPE Project, Cheltenham, UK
Communicating the oncological diagnosis: a psycho-oncological perspective
Expert: Adrian Pogacian, INCKA Psycho-Oncology Center, Târgu Mures, Romania
ESMO 2023 Highlights on lung cancer
Expert: Mohamed Emam Sobeih, National Cancer Institute Cairo, Nasr City, Egypt
Cyclophosphamide induced severe hyponatremia with encephalopathy and seizure in a patient with locally advanced breast cancer
Expert: Sofiko Sharashenidze, Mardaleishvili Medical Centre, Tbilisi, Georgia
COVID-19 in cancer patients: update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databases
Expert: Salah Mabrouk Khallaf, South Egypt Cancer Institute, Assiut, Egypt
Radiotherapy as a local hemostatic agent in cancer patients
Expert: Mohammad Nasser Ahmed, National Oncology Center, Sanaa, Yemen Republic
News on Breast Cancer from ESMO 2023
Expert: Elvina Almuradova, Medicana International Hospital, Izmir, Turkey
Challenge of diagnosis of metachronous ovarian metastases in a young patients with primary colorectal cancer
Expert: Zaiana Sangadzhieva, Institute for Personalized Oncology of Sechenov University, Moscow, RU
How to make the treatment choice in localized adenocarcinoma of the lower oesophagus and GEJ after the NeoAegis trial results
Expert: Marcelo Porfirio Sunagua Aruquipa, Grupo Oncoclinicas, San Paolo, Brazil
THE ERA OF CDK4/6 inhibitors in early breast cancer concerning staging the axilla. A surgeon’s perspective
Expert: Lazaros Papadopoulos, IASO Gynecological Clinic, Athens, Greece
SELNET clinical practice guidelines for bone sarcoma
Expert: Bruna David, National Cancer Institute, Rio de Janeiro, Brazil
Switching treatment paradigms and the difficulties with this
Experts:
Sara Ramella, Campus Bio-Medico University, Rome, Italy
Pierfilippo Crucitti, Campus Bio-Medico University, Rome, Italy
Ripretinib for the treatment of adult patients with advanced gastrointestinal stromal tumors
Expert: Amalya Sargsyan, Hematology Center After Prof Yeolyan, Yerevan, Armenia
Surgical management of breast cancer in BRCA-mutation carriers
Expert: Nicola Rocco, University Hospital Federico II, Naples, Italy
ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma - Radiotherapy and Oncology
Expert: Sara Simões, Braga Public Hospital, Braga, Portugal
The usage of AI in oncology
Expert: Livio Fenga, University of Exeter
Exeter, United Kingdom
Clinical use of radiomics
Expert: Stefania Volpe, European Institute of Oncology Milan and University of Milan, Milan, Italy
Why do we need mentoring in oncology
Expert: Malgorzata Osmola, University Clinical Centre - Medical University of Warsaw, Warsaw, Poland
Lessons from the ANCHOR-CRC Trial: The challenge of BRAF in metastatic Colorectal Cancer
Expert: Marcelo Porfirio Sunagua Aruquipa, AC Camargo Cancer Center, San Paolo, Brazil
Tumor treating fields in thoracic malignancies
Expert: Mohamed Emam Sobeih, National Cancer Institute Cairo, Nasr City, Egypt
ESO CTC Fellowship Programme: achievements during 6 months at the Istituto Nazionale dei Tumori
Fellow: Silvia Brotea-Mosoiu, Oncology Institute of Bucharest, Bucharest, Romania
Mentor: Salvatore Provenzano, Fondazione IRCCS Istituto Nazion...
Latest Practice Changing Studies for treatment Endometrial Carcinoma
Expert: Elvina Almuradova, Medicana International Hospital, Izmir, Turkey